Clinical Inertia in Diabetes: Is it Really a Problem?
The Journal for Nurse Practitioners
First page number:
Last page number:
Type 2 diabetes mellitus (T2DM) is a progressive disease where patients experience a decline in the beta cell function over time and require increasing therapeutic intervention to manage appropriately. The American Diabetes Association (ADA) Standards of Medical Care in Diabetes (2019)1 included new summary changes emphasizing the need for ongoing assessment and avoiding clinical inertia. The term clinical inertia has been defined as the failure of a health care provider to intensify or initiate therapy as indicated.2 Clinical inertia is seen as a complex interaction between patient and provider. It is dynamic and involves patients, providers, health care systems and barriers to practice and care.
Clinical inertia; Type 2 diabetes mellitus; T2DM; Oral antidiabetic medications; Diabetes treatment
Endocrinology, Diabetes, and Metabolism | Medical Specialties | Medicine and Health Sciences
VanBeuge, S. S.
Clinical Inertia in Diabetes: Is it Really a Problem?.
The Journal for Nurse Practitioners, 16(2),